Intraoperative blood loss is frequently an overarching concern during total hip arthroplasty (THA) for patients who have ankylosing spondylitis with hip involvement. However, the factors that affect blood loss have not been identified. The goal of this study was to investigate these factors among patients with ankylosing spondylitis. Patients in the authors' department who had ankylosing spondylitis and underwent unilateral THA from 2011 to 2016 were studied retrospectively. Demographic characteristics, perioperative laboratory values, intraoperative data, transfusion rate, transfusion volume, and data on hemostatic use were collected and analyzed statistically. Multiple and univariate linear regression analyses were performed. As a result, 44 patients were eligible for inclusion in the study. Mean age was 31.7±10.6 years, and mean disease duration was 9.7±5.8 years. Mean body mass index was 21.30±3.01 kg/m 2 . Mean volume of blood loss during THA was 1735.19±756.04 mL. Multiple linear regression analysis showed that perioperative blood loss was positively associated with Ankylosing Spondylitis Disease Activity Score (ASDAS), fibrinogen concentration, and surgical time. Further evaluation with univariate linear regression analysis suggested that ASDAS, red blood cell transfusion, and change of hematocrit concentration from preoperatively to postoperatively were correlated with blood loss. Disease activity, allogeneic blood transfusion volume, and change of hematocrit concentration from preoperatively to postoperatively appeared to be positively associated with perioperative blood loss during THA for patients with ankylosing spondylitis. For these patients, disease activity and the potential for allogeneic transfusion should be considered carefully before surgery. [Orthopedics. 201x; xx(x):xx-xx.] abstract longer surgical time among patients with ankylosing spondylitis. 3 Moreover, patients with ankylosing spondylitis have a high potential for thrombosis. 4 As a consequence, the risk of postoperative bleeding is much higher because of the powerful anticoagulation strategy that is needed to prevent deep venous thrombosis. However, this treatment often results in hidden blood loss.
Obviously, it is important to reduce perioperative blood loss during THA for patients with ankylosing spondylitis, and there has been considerable debate on the factors that affect blood loss after THA. [5] [6] [7] [8] However, little is known about the effect of disease specificity of ankylosing spondylitis on blood loss during THA. The current study investigated the factors that affect blood loss during THA.
Materials and Methods

Patients
From 2011 to 2016, a total of 56 patients with ankylosing spondylitis underwent unilateral THA in the authors' department. Demographic characteristics, including sex, age, height, weight, and disease duration, were obtained. Patients with other rheumatic diseases or a history of hematologic disease, including coagulation disorders, thrombocytopenia, and other hemorrhagic disorders, were excluded. Patients with long-term use of anticoagulation drugs also were excluded. Overall, 44 patients were eligible for this study.
Indications for Surgery, Surgical Procedure, and Perioperative Management
Refractory pain or disability and radiographic evidence of structural damage of the hips (regardless of age) are signs of ankylosing spondylitis among patients undergoing THA. 9 All of the patients underwent surgery with a lateral approach performed by the same experienced team. The length of the incision ranged from 10 to 15 cm. All procedures were performed with the patient in the supine position. General anesthesia or spinal anesthesia was used. Cephalosporin antibiotics were routinely administered for 24 hours perioperatively to prevent infection. Hemocoagulase agkistrodon (HCA) or tranexamic acid (TXA) was injected postoperatively. To prevent venous thromboembolism, mechanical prophylaxis rather than treatment with anticoagulation drugs was initiated immediately after surgery.
Clinical Data
The following data were collected for all patients: preoperative laboratory findings, including C-reactive protein level, erythrocyte sedimentation rate, hemoglobin concentration, hematocrit concentration, platelet concentration, coagulation test index (prothrombin time, prothrombin activity, prothrombin time/international normalized ratio, activated partial thromboplastin time, thrombin time, fibrinogen concentration, and albumin concentration), postoperative hematocrit concentration, surgical time, allogeneic transfusion, autologous transfusion of wound blood after cell salvage processing, and strategy for hemostatic use.
Transfusion Management and Estimation of Blood Loss
Both allogeneic and autologous transfusions were implemented during surgery and postoperatively, based on the condition of the patient. Based on the British guideline 10 and clinical judgment, the transfusion triggers had 2 components. The first trigger was a hemoglobin concentration of less than 70 g/L and a hematocrit concentration of less than 25%. For patients older than 65 years and those with cardiovascular disease, a hemoglobin concentration of less than 80 g/L was a transfusion trigger. In addition, a combination of large estimated blood loss (>15% of blood volume, or approximately 800 mL) during surgery with clinical manifestations, including a decrease in blood pressure (<90/60 mm Hg), pale lips, dizziness, weakness, and shortness of breath, was considered acute anemia, which was also a transfusion trigger.
Perioperative blood loss was estimated with the Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) formula (Table 1) .
11,12
Assessment of Disease Activity
The Ankylosing Spondylitis Disease Activity Score (ASDAS), a highly discriminatory index recommended by the Assessment of SpondyloArthritis International Society, 13 was used to evaluate the disease activity of ankylosing spondylitis. Patient-reported outcomes and C-reactive protein levels were included in the ASDAS ( Table 1) .
Statistical Analysis
The study was approved by the institutional review board at the study hospital. All statistical analyses were performed with SPSS for Windows version 23.0 software (SPSS, Armonk, New York). Continuous data were presented as mean±SD. Multiple regression analysis that was used effectively by other investigators 14, 15 was performed to evaluate factors that affect perioperative blood loss during THA for patients with ankylosing spondylitis and ankylosis of the hip. A stepwise method was used. Multiple regression analysis was performed with 16 independent variables, including age, sex, body mass index, disease duration, ASDAS, and the following preoperative laboratory results: hemoglobin concentration, platelet concentration, prothrombin time, prothrombin activity, prothrombin time/international normalized ratio, activated partial thromboplastin time, thrombin time, fibrinogen concentration, and albumin concentration. Also included were surgical time and hemostatic use. For qualitative variables, female sex was set as "0" and male sex was set as "1." For hemostatic use, "neither of HCA or TXA was used" was set as "0," "only HCA was used" was set as "1," "only TXA was used" was set as "2," and "both of HCA and TXA were used" was set as "3."
Spearman's correlation analysis showed that ASDAS was strongly correlated with C-reactive protein level (P<.001) and erythrocyte sedimentation rate (P<.001). To increase the accuracy of the results, ASDAS, which was considered more comprehensive and reliable, was selected as the independent variable for multiple regression analysis.
For further evaluation, univariate linear regression analysis was performed according to the findings of multiple linear regression analysis. In addition, univariate linear regression in which the variables were change in hematocrit concentration from preoperatively to postoperatively and volume of allogeneic blood transfusion (red blood cell transfusion), respectively, was performed based on the OSTHEO formula. Statistical significance was set at P<.05.
results
This study included 44 patients with ankylosing spondylitis, including 5 female and 39 male patients, all of whom had end-stage hip disease. Demographic features, laboratory values, ASDAS, surgical time, and hemostatic use are shown in Table 2 . According to the ASDAS classification, more patients had active disease (ASDAS≥1.3) than stable disease (ASDAS<1.3).
Mean volume of allogeneic blood transfusion (red blood cell transfusion) was 1.86 units, and the transfusion rate was 79.5%. Mean perioperative blood loss during THA was 1735.19±756.04 mL.
Multiple and stepwise linear regression analysis showed that ASDAS, surgical time, and preoperative fibrinogen concentration were positively correlated with perioperative blood loss ( Table  3) . Univariate linear regression analysis showed that ASDAS, change of hematocrit concentration, and volume of allogeneic blood transfusion were correlated with blood loss (Table 4) .
discussion
When evaluating the safety of a procedure, surgeons most commonly consider blood loss. Previous researchers 3 showed that THA results in much greater blood loss for patients with ankylosing spondylitis than for patients with osteoarthritis. The current study showed that the volume of perioperative blood loss was 1735.19±756.04 mL for patients with ankylosing spondylitis, which is considered very high. Shen et al 6 reported mean perioperative blood loss for THA of 1438±412 mL for patients with osteoarthritis. However, Miao et al 5 reported less blood loss during THA (1155±377 mL). The current study found much more blood loss than the studies by Miao et al 5 and Shen et al. 6 The reason underlying the difference needs further discussion.
An extensive review of the literature showed that many risk factors for blood loss in THA have been reported, but few studies have focused on ankylosing spondylitis. Miao et al 5 indicated that sex, age, body mass index, blood transfusion, change of hematocrit concentration from preoperatively to postoperatively, and diagnosis affected hidden blood loss after THA. However, Lošťák et al 8 reached a different conclusion and found that the factors that affected the volume of blood loss after THA included body mass index, American Society of Anesthesiologists score, blood recuperation, and smoking habits, but did not include age, sex, primary diagnosis, type of prophylaxis for deep venous thrombosis, or type of implant fixation. 8 Shen et al 6 reported that sex, body mass index, surgical time, blood transfusion, and decrease in hematocrit concentration from preoperatively to postoperatively were the factors that affected blood loss after THA for patients with osteoarthritis. It was reported previously that body mass index was associated with blood loss after THA for patients with ankylosing spondylitis. 7 In the current study, multiple and stepwise linear regression analysis showed that ASDAS, fibrinogen concentration, and surgical time were positively related to perioperative blood loss ( Table 3) . How- To increase the reliability of the result, postoperative Hct was obtained from the laboratory test, which was carried out at 6:00 aM 1 day after surgery. Only transfusions that were executed before phlebotomy for laboratory tests were included in the study.
ASDAS-CRP:
ASDAS-CRP=0.121×Back pain+0.058×Duration of morning stiffness+0.110×Patient global+0.073×Peripheral pain/swelling+0.579×ln(CRP+1)
The following suggestion was based on the ASDAS-CRP classification: ASDAS<1.3, stable; 1.3≤ASDAS<2.1, moderately active; 2.1≤ASDAS≤3.5, highly active; ASDAS>3.5, very highly active.
Abbreviations: ASDAS, Ankylosing Spondylitis Disease Activity Score; CRP, C-reactive protein level; EBV, estimated blood loss volume; Hct, hematocrit concentration; RBC, red blood cell count.
ever, univariate linear regression analysis showed that ASDAS, change of hematocrit concentration from preoperatively to postoperatively, and red blood cell transfusion were correlated with blood loss (Table 4) .
Fibrinogen is a glycoprotein in vertebrates that helps with the formation of blood clots. When fibrinogen concentration increases, thrombosis is more likely to occur, along with increased red blood cell count and platelet aggregation as well as improved blood viscosity. As shown in Table 3 , fibrinogen concentration seemed to be negatively correlated with surgical bleeding. Therefore, higher levels of fibrinogen may lead to less bleeding. Further univariate linear regression analysis showed no relationship between fibrinogen concentration and blood loss. The authors believe that there may be an association between them but not an absolute linear relationship. So et al 16 showed that patients with ankylosing spondylitis have higher levels of thrombin-antithrombin III complexes, prothrombin fragment F1+2, and D-dimers in their plasma, which would indicate that patients with ankylosing spondylitis have hypercoagulability. Many surgeons have noticed this problem. As a result, more potent anticoagulation is used to prevent thrombosis among these patients. However, this treatment results in more hidden blood loss after surgery. Previous studies have evaluated hidden blood loss, 5, 6, 17 and it can reach 1050 mL. 18 Wendling and Racadot 19 found that tissue factor levels were correlated with inflammation in ankylosing spondylitis. Contrary to the findings of Wendling and Racadot, 19 So et al 16 showed that tissue factor activity in the plasma did not increase significantly among patients with ankylosing spondylitis, and a mechanism of coagulation activation that is not mediated by tissue factor could explain the findings of higher levels of thrombinantithrombin III complexes and prothrombin fragment F1+2 in patients with ankylosing spondylitis. The current authors hypothesized that there is much greater consumption than production of clotting factors related to the endogenous coagulation pathway because of constant activation of the endogenous coagulation cascade reaction and the subsequent fibrinolysis reaction. The result is a shortage of clotting factors as well as an increase in activated partial thromboplastin time. The current findings agreed with this hypothesis (mean activated partial thromboplastin time, 32.95 s; median, 33.30 s; normal, <31.8 s). Prati et al 20 showed a delay in thrombin generation for patients with ankylosing spondylitis, and this may be a reason for increased blood loss. Miao et al 5 and Shen et al 6 found that age, sex, and body mass index affected blood loss during THA, results that contradict the current findings. In the authors' view, this difference was caused by the distinctive features of ankylosing spondylitis. Ankylosing spondylitis with hip involvement mostly affects adolescent boys, and mean age of the patients in the current study was 31.7±10.6 years, with a maleto-female ratio of 38:5.
Many studies have shown that surgical time and body mass index are independent factors that affect blood loss after THA, although the current findings were inconsistent with previous findings. Ankylosing spondylitis is a chronic autoimmune disease that includes spondyloarthritis and extra-articular involvement, and the morbidity rate and manifestations vary with the different types. El Maghraoui et al 21 reported that extra-articular manifestations vary widely in terms of both frequency and severity for patients with ankylosing spondylitis, and the most common extra-articular manifestations are uveitis, bowel disease, and lung, heart, skin, bone, and kidney involvement. Rimbas et al 22 reported that the morbidity rate for patients with bowel lesions was approximately 20%, which was a striking finding because it was much higher than expected. From another perspective, many studies, both in China and internationally, showed that patients with ankylosing spondylitis often have mental illness, such as anxiety, insomnia, and depression. Unlike other patients, those with ankylosing spondylitis often have long-term pain, both mentally and physically. Therefore, the systematic effect of ankylosing spondylitis differentiates it from ordinary hip arthropathy. The findings may be misleading because of the much smaller effect of surgical time and body mass index on blood loss relative to other factors.
Disease activity, which is well reflected by ASDAS, was proven to be positively correlated with perioperative blood loss. First, disease activity may be correlated with the immune inflammatory reaction.
Some studies showed that the occurrence and progression of ankylosing spondylitis are closely associated with various inflammation-relevant cytokines, and some also are positively related to disease activity, including soluble interleukin-2 receptor, interleukin-6, interleukin-33, 23 and tumor necrosis factor alpha, 24 which may trigger an inflammatory reaction. The authors suggest that this reaction may be closely associated with local pathologic progression of hip arthritis. For patients with active ankylosing spondylitis, inflammation may be acute rather than chronic, based on the significantly higher total oxidative status. 25 Acute inflammatory progression of the hip, with local hemangiectasis, accelerated blood flow, local vascular damage, 26 increased capillary permeability, subsequent microvascular proliferation, 27 and increased leukocyte count, 28 results in more intraoperative and postoperative blood loss when the disease is active.
Second, the mechanism of how disease activity influences blood loss in patients with ankylosing spondylitis may be associated with serum and intra-articular changes of the coagulation and fibrinolytic systems. The authors hypothesized that the intra-articular pathophysiologic change among patients with active ankylosing spondylitis is similar to the progression of disseminated intravascular coagulation, which is characterized by local formation of microthrombi and blood coagulation dysfunction, based on systemic activation of coagulation and fibrinolysis 16, 20 and intra-articular activation. 16, 29, 30 In the current study, the coefficient of determination (R 2 ) of the multiple linear regression model, which included ASDAS, fibrinogen concentration, and surgical time, was 0.302. Disease activity, fibrinogen concentration, and prolonged surgical time may account for nearly onethird of cases of increased perioperative bleeding. Individual univariate linear regression analysis showed that disease activity was the most important factor. To determine the factors responsible for increased blood loss, univariate linear regression was performed with change of hematocrit concentration from preoperatively to postoperatively and volume of allogeneic blood transfusion (red blood cell transfusion). As shown in Table 4 , R 2 values were 0.185 and 0.384, respectively. Red blood cell transfusion obviously accounted for much more blood loss than change of hematocrit concentration. The allogeneic transfusion rate was 79.5%, and mean volume was nearly 2 units. The results suggested great potential for transfusion. The authors believe that the underlying hemolytic reaction, which is not large enough to manifest, may result in more hidden blood loss. Pattison et al 31 proposed the phenomenon of hemolysis. They suggested that a hemolytic process may account for a sudden postoperative reduction in hemoglobin concentration for patients undergoing reconstructive arthroplasty.
Limitations
This study was limited by the sample size and the limited demographic features of the cohort (5 women, very low and narrow range of body mass index [21.30±3.01 kg/m 2 ], and young cohort [31.7±10.6 years]). However, based on the epidemiologic features of ankylosing spondylitis, [32] [33] [34] the male-to-female ratio for incidence is 6.1:1 in Asia, and hip involvement is common in male patients. The disease generally presents at approximately 26 years of age, and average body mass index of affected patients was reported to be 22.8±3.1 kg/m 2 . The authors consider the limited demographics of the cohort as a typical sample representing the epidemiologic features of ankylosing spondylitis. In addition, the effects of other potential factors, such as comorbidities affecting some of the enrolled patients, cup size and manufacturing errors affecting the implant, congenital anomaly of the hip anatomy, smoking habits, and bone mineral density, must be determined. These factors may account for the additional 12.9% effect on perioperative blood loss during THA among patients with ankylosing spondylitis.
conclusion
Disease activity, volume of allogeneic blood transfusion, and change of hematocrit concentration from preoperatively to postoperatively appear to be positively associated with perioperative blood loss during THA for patients with ankylosing spondylitis. Fibrinogen concentration and surgical time may be related to blood loss but do not show an absolute linear relation. The specific correlation remains unknown. Therefore, disease activity and the potential for allogeneic transfusion should be considered carefully before surgery. Efforts to control the disease activity of ankylosing spondylitis may decrease blood loss during THA and improve the safety of the procedure. Currently, tumor necrosis factor inhibitors, including adalimumab, etanercept, golimumab, and infliximab, can be used to control the disease activity of ankylosing spondylitis.
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